Guardant360 Test: Liquid Biopsy, Cancer Mutations, ctDNA, and Genomic Profiling
Guardant360 is a family of blood-based genomic profiling tests used mainly for people with advanced solid cancers. The current U.S. FDA-approved platform, Guardant360 Liquid...
KRAS Liquid Biopsy Test: Colon, Lung, Pancreatic Cancer, Mutation Status, and ctDNA Meaning
A KRAS liquid biopsy is a blood test that looks for tumor-derived KRAS mutations in circulating tumor DNA (ctDNA). It can help characterize some...
Liquid Biopsy Resistance Mutation Test: Cancer Drug Resistance Markers and Mutation Detection
A liquid biopsy resistance mutation test looks for genetic changes in circulating tumor DNA (ctDNA) that can explain why a cancer has stopped responding—or...
Liquid Biopsy Test: Circulating Tumor DNA, Blood-Based Tumor Testing, and Mutation Detection
A liquid biopsy is a laboratory test that looks for cancer-related material in blood or another body fluid instead of removing a piece of...
OncoBEAM Test: ctDNA Mutation Testing, Digital PCR, and Blood-Based Monitoring
OncoBEAM is a highly sensitive liquid-biopsy approach that uses BEAMing digital PCR to detect selected tumor mutations in circulating tumor DNA (ctDNA) from plasma....
RaDaR Test: ctDNA MRD, Cancer Monitoring, and Recurrence Detection
RaDaR is a personalized blood test that looks for tiny amounts of circulating tumor DNA (ctDNA) after a cancer has been treated or while...
Signatera Test: ctDNA MRD, Cancer Recurrence, and Personalized Monitoring
Signatera is a personalized circulating tumor DNA (ctDNA) blood test used to look for molecular residual disease (MRD) and to monitor cancer over time....
Tempus xF Test: Liquid Biopsy, Cancer Genomics, ctDNA, and Mutation Results
Tempus xF is a blood-based next-generation sequencing test that analyzes circulating tumor DNA (ctDNA) to look for genomic changes in solid cancers. Its main...
Tumor-Informed ctDNA Test: Personalized MRD Monitoring, Recurrence Detection, and Result Meaning
A tumor-informed ctDNA test is a personalized blood test built from genetic changes found in a patient’s own cancer. It is most often used...
Tumor-Naive ctDNA Test: Blood-Based Cancer Monitoring Without Tumor Tissue
A tumor-naive ctDNA test looks for cancer-related DNA signals in blood without first sequencing that patient’s tumor to build a custom assay. Also called...
ALK Test for Anaplastic Large Cell Lymphoma: Fusion Marker, Positive Result, and Tumor Classification
An ALK test helps determine whether an anaplastic large cell lymphoma (ALCL) belongs to the ALK-positive subtype, a biologically distinct form of systemic T-cell...
BCL2 Rearrangement Test: Follicular Lymphoma, Rearrangement Status, and FISH Result
A BCL2 rearrangement test looks for a structural change involving the BCL2 gene, most often the classic IGH::BCL2 fusion created by t(14;18)(q32;q21). This abnormality...
BCR-ABL1 Quantitative PCR Test: CML Monitoring, Molecular Response, and Transcript Level
The BCR-ABL1 quantitative PCR test is the main blood test used to monitor molecular response in chronic myeloid leukemia (CML). It measures the amount...
BCR-ABL1 Test: Chronic Myeloid Leukemia, Philadelphia Chromosome, and Molecular Diagnosis
A BCR-ABL1 test looks for the abnormal BCR::ABL1 fusion gene that defines chronic myeloid leukemia (CML) and can also occur in some acute leukemias....
Beta-2 Microglobulin Test for Myeloma: Staging, Prognosis, Tumor Burden, and Kidney Function
A beta-2 microglobulin test measures a small protein in blood that is used as part of staging and prognosis in multiple myeloma. In myeloma,...
BTK Mutation Test: CLL Drug Resistance Marker and Mutation Meaning
A BTK mutation test looks for acquired changes in the Bruton tyrosine kinase gene that can help explain resistance to BTK inhibitor treatment in...
CALR Mutation Test: Essential Thrombocythemia, Myelofibrosis, Platelets, and Mutation Meaning
A CALR mutation test looks for acquired mutations in the calreticulin gene that are strongly associated with certain myeloproliferative neoplasms, especially essential thrombocythemia (ET)...
CCND1/IGH Fusion Test: Mantle Cell Lymphoma, Cyclin D1, and FISH Result
A CCND1/IGH fusion test looks for the genetic rearrangement created by t(11;14)(q13;q32), the hallmark chromosome abnormality in most mantle cell lymphomas (MCL). The translocation...
CD19 Test: B-Cell Leukemia, Lymphoma, CAR-T Marker, and Positive Staining
A CD19 test checks whether cells express CD19, a surface protein found across most of the B-cell lineage. In hematologic cancer, CD19 is usually...
CD20 Test: B-Cell Lymphoma Marker, B-Cell Lineage, and Positive Staining
A CD20 test checks whether cells express CD20, a surface protein found on most mature B lymphocytes. In lymphoma diagnosis, CD20 is commonly assessed...